94 related articles for article (PubMed ID: 6168909)
1. Urine from patients with transitional-cell carcinoma stimulates migration of capillary endothelial cells.
Chodak GW; Scheiner CJ; Zetter BR
N Engl J Med; 1981 Oct; 305(15):869-74. PubMed ID: 6168909
[No Abstract] [Full Text] [Related]
2. Angiogenesis and neoplasia.
Gullino PM
N Engl J Med; 1981 Oct; 305(15):884-5. PubMed ID: 6168910
[No Abstract] [Full Text] [Related]
3. Urinary and tissue levels of scatter factor in transitional cell carcinoma of bladder.
Rosen EM; Joseph A; Jin L; Yao Y; Chau MH; Fuchs A; Gomella L; Hastings H; Goldberg ID; Weiss GH
J Urol; 1997 Jan; 157(1):72-8. PubMed ID: 8976219
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of angiogenesis in transitional cell carcinoma of the human urinary bladder.
Dickinson AJ
Br J Urol; 1996 Nov; 78(5):808. PubMed ID: 8976796
[No Abstract] [Full Text] [Related]
5. An endogenous inhibitor of angiogenesis derived from a transitional cell carcinoma: clipped beta2-glycoprotein-I.
Beecken WD; Engl T; Ringel EM; Camphausen K; Michaelis M; Jonas D; Folkman J; Shing Y; Blaheta RA
Ann Surg Oncol; 2006 Sep; 13(9):1241-51. PubMed ID: 16955386
[TBL] [Abstract][Full Text] [Related]
6. What is the role of endothelial cells in angiogenesis?
Folkman J
Lab Invest; 1984 Dec; 51(6):601-4. PubMed ID: 6209467
[No Abstract] [Full Text] [Related]
7. Our experience with a new method of urinary cytology during cystoscopy.
Defidio L; Naslund I; De Paula F; Pansadoro V
Prog Clin Biol Res; 1988; 260():275-81. PubMed ID: 3362884
[No Abstract] [Full Text] [Related]
8. Vascular endothelial growth factor-C (VEGF-C) expression predicts lymph node metastasis of transitional cell carcinoma of the bladder.
Suzuki K; Morita T; Tokue A
Int J Urol; 2005 Feb; 12(2):152-8. PubMed ID: 15733109
[TBL] [Abstract][Full Text] [Related]
9. Tumor angiogenesis correlates with lymph node metastases in invasive bladder cancer.
Jaeger TM; Weidner N; Chew K; Moore DH; Kerschmann RL; Waldman FM; Carroll PR
J Urol; 1995 Jul; 154(1):69-71. PubMed ID: 7539869
[TBL] [Abstract][Full Text] [Related]
10. Wound fluid angiogenesis factor stimulates the directed migration of capillary endothelial cells.
Banda MJ; Dwyer KS; Beckmann A
J Cell Biochem; 1985; 29(3):183-93. PubMed ID: 4077928
[TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of micro-vessel density in cancer of the urinary bladder.
Chaudhary R; Bromley M; Clarke NW; Betts CD; Barnard RJ; Ryder WD; Kumar S
Anticancer Res; 1999; 19(4C):3479-84. PubMed ID: 10629639
[TBL] [Abstract][Full Text] [Related]
12. Assessment of the VEGF, bFGF, aFGF and IL8 angiogenic activity in urinary bladder carcinoma, using the mice cutaneous angiogenesis test.
Rogala E; Skopińska-Rózewska E; Sommer E; Pastewka K; Chorostowska-Wynimko J; Sokolnicka I; Kazoń M
Anticancer Res; 2001; 21(6B):4259-63. PubMed ID: 11908679
[TBL] [Abstract][Full Text] [Related]
13. Combined assay of CYFRA21-1, telomerase and vascular endothelial growth factor in the detection of bladder transitional cell carcinoma.
Bian W; Xu Z
Int J Urol; 2007 Feb; 14(2):108-11. PubMed ID: 17302565
[TBL] [Abstract][Full Text] [Related]
14. Detection of bladder tumor by urine cytology in cases of prostatic hypertrophy.
Rammou-Kinia R; Anagnostopoulou I
Diagn Cytopathol; 1996 Dec; 15(5):409-11. PubMed ID: 8989544
[TBL] [Abstract][Full Text] [Related]
15. [Microsatellite instability in urine sediments from patients with transitional cell carcinoma of bladder and its clinical value].
Lü Y; Tang D; Yu L; Ding Y; Liu L; Guo Y
Zhonghua Wai Ke Za Zhi; 2000 Apr; 38(4):294-6. PubMed ID: 12828175
[TBL] [Abstract][Full Text] [Related]
16. Initial evaluation of CYFRA 21-1 diagnostic performances as a urinary marker in bladder transitional cell carcinoma.
Pariente JL; Bordenave L; Michel P; Latapie MJ; Ducassou D; Le Guillou M
J Urol; 1997 Aug; 158(2):338-41. PubMed ID: 9224298
[TBL] [Abstract][Full Text] [Related]
17. Survivin mRNA expression in urine as a biomarker for patients with transitional cell carcinoma of bladder.
Hou JQ; He J; Wen DG; Chen ZX; Zeng J
Chin Med J (Engl); 2006 Jul; 119(13):1118-20. PubMed ID: 16834932
[No Abstract] [Full Text] [Related]
18. Molecular pathways in bladder cancer: part 2.
Bryan RT; Hussain SA; James ND; Jankowski JA; Wallace DM
BJU Int; 2005 Mar; 95(4):491-6. PubMed ID: 15705066
[No Abstract] [Full Text] [Related]
19. [Urinary BTA-TRAK in the follow-up of superficial transitional-cell bladder carcinoma].
Fernández Gómez JM; García Rodríguez J; Escaf Barmadah S; Raigoso P; Rodríguez Martínez JJ; Allende MT; Casasola Chamorro J; Rodríguez Faba O; Martín Benito JL; Regadera Sejas FJ
Arch Esp Urol; 2002; 55(1):41-9. PubMed ID: 11957750
[TBL] [Abstract][Full Text] [Related]
20. Urine prothymosin-alpha as novel tumor marker for detection and follow-up of bladder cancer.
Tzai TS; Tsai YS; Shiau AL; Wu CL; Shieh GS; Tsai HT
Urology; 2006 Feb; 67(2):294-9. PubMed ID: 16461079
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
